Arcapita and Mumtalakat sells stake in NAS Neuron Health Services
Arcapita Group Holdings and Bahrain’s Mumtalakat Holding Company have announced the sale of their stake in NAS Neuron Health Services to a US based Fortune 500 company. The successful investment has exceeded target returns over a three-year holding period. During these past three years, Arcapita and Mumtalakat supported NAS Neuron's execution of a series of organic and inorganic growth initiatives, including the business combination with another major UAE third-party administrator, Neuron; the implementation of a variety of strategic initiatives to drive customer growth and reduce costs, and the roll-out of healthcare technology services among its clients.
Atif A. Abdulmalik, Arcapita's Chief Executive Officer, commented, "We are pleased to have achieved this exit in the current economic environment. In addition, the success of our investment in NAS Neuron highlights the resilience of the UAE and GCC private equity market as well as the attractiveness of the region's healthcare sector to global investors despite a challenging economic environment.”
According to Abdulmalik, healthcare and wellness will be Arcapita’s focus areas for both private equity and real estate platforms given the demographic tailwinds supporting this sector that are supported by long-term market fundamentals.
HE Khalid Al Rumaihi, Chief Executive Officer of Mumtalakat said, "Our strategic partnership with Arcapita enabled us to support and witness NAS Neuron's progress into one of the leading players in the GCC health sector with a solid management structure, and a clear vision to continue on its growth trajectory. The successful culmination and positive outcome of this venture is a validation of the robust and sound nature of our collective business strategy, and is in line with our efforts towards maintaining a diverse and sustainable portfolio."
